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Abstract
Mechanical circulatory support (MCS) is a lifesaving procedure in patients with
refractory cardiogenic shock. Despite improvement in surgical techniques, ICU
care and restored hemodynamics, some patients on MCS remain severely
debilitated due to multiple medical problems, including infections, respiratory
failure, de-conditioning and nutritional deficits.
Here we present a case of a patient with persistent high degree fever, devastating
muscle weakness, and elevated lactatedehydrogenase (LDH) level, who
dramatically responded to treatment with vitamin B 12.
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Introduction
Mechanical circulatory support (MCS) is a lifesaving treatment for patients with
refractory cardiogenic shock1. Despite improvement in surgical techniques,
intensive care and restored hemodynamics, some patients on MCS remain
severely debilitated due to multiple medical problems, including infections,
respiratory failure, de-conditioning and nutritional deficits2. Here we present a case
of a patient with persistent high degree fever, devastating muscle weakness, and
an elevated lactate dehydrogenase (LDH) level, who dramatically responded to
treatment with vitamin B 12.
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Case Report
Early Experience
A 25-year-old male with history of repaired truncus arteriosus, placement of right
ventricle-to-pulmonary artery homograft, bioprosthetic aortic valve replacement
and severe left ventricular dysfunction, presented with cardiogenic shock, hypoxia
and acute renal failure on June 1, 2015. He initially required veno-arterial
extracorporeal membrane oxygenation (VA ECMO) support and continuous venovenous hemofiltration (CVVH). Transesophageal echocardiogram showed a
severely dilated left ventricle with an ejection fraction of 10%, severe prosthetic
aortic valve stenosis, severe mitral valve regurgitation secondary to a flailed
posterior leaflet segment, and moderate pulmonary stenosis. Trans-catheter aortic
valve replacement was performed, which did not improve the patient’s condition.
The patient developed thrombocytopenia and anemia, and required multiple blood
transfusions.
On June 24, 2015, the patient underwent Heartmate II left ventricular assist device
(LVAD) implantation with mitral valve repair and replacement of the right ventricle
to pulmonary artery conduit. Despite normalization of cardiac hemodynamics and
recovery of renal function, the patient’s condition progressively worsened during
the five weeks after surgery. He required a tracheostomy after failing several
weaning trials due to an inability to clear secretions and poor oxygenation. He
remained ventilator dependent in the ICU for six weeks.
During this time, he developed persistent high fevers up to 40°C which did not
respond to multiple broad spectrum antibiotics and were resistant to antipyretics
(Figure 1A). Blood cultures and bronchoalveolar lavages were all negative for an
infectious etiology. Full body scans, including computed tomography (CT),
positron emission tomography (PET), and an echocardiogram did not reveal a
source of infection. All markers of autoimmune disease were negative.

Figure 1A
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In addition, the patient developed profound muscle weakness. A CT scan of the
brain was unremarkable, electromyography (EMG) of lower extremities was
inconclusive, and his neurological symptoms were attributed to critical illness
myopathy.
The patient developed anemia with macrocytosis and required several blood
transfusions. His LDH level was elevated at 630 U/L (reference range 98-182 U/L),
but there were no clinical signs of LVAD thrombosis. His vitamin B12 level was
within the normal reference range, and a methylmalonic acid (MMA) level was at
upper limit of the normal reference range (Table 1). Based on our previous
experience with vitamin B12 treatment in the setting of fever of unknown origin 3,
oral vitamin B12 supplementation was initiated. There was resolution of the fever
four days after vitamin B12 initiation (Figure 1B). Importantly, no changes in
antibiotics or other medications were made at this time. There was also a dramatic
improvement in neurological symptoms. The patient was weaned from mechanical
ventilation one week later. He was transferred to the cardiac step down unit ten
days after initiating vitamin B12. He continued to improve with regard to his
neurological condition and was discharged home from the rehabilitation unit after
one month. His fever did not recur.

Vitamin B 12 started

Weaned from
Mechanical ventilation

Transferred
from ICU

Figure 1B
Table 1 shows the hematologic data obtained prior to initiation of vitamin B12
supplementation, one and two months after initiation vitamin B12 supplementation.
The level of vitamin B12 increased, the concentration of MMA decreased, and the
LDH level returned to normal range.
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Table 1. The hematologic data before and after vitamin B12 supplementation
Reference range

7/15/201*

8/15/2015†

9/15/2015‡

MCV, fL/red cell

80-96

101

98

95

Vitamin B12, pg/mL

180-914

473

975

MMA, μmol/L

0.00-0.40

0.4

0.2

LDH, U/L

98-192

650

367

284

* 2 weeks prior to initiation of vitamin B12 supplementation,
† 2 weeks after initiation of vitamin B12 supplementation,
‡ 6 weeks after initiation of vitamin B12 supplementation

Discussion
The important role of vitamin B12 and it deficiency in the hematological and
neurological processes in human body has been well documented. However,
vitamin B12 deficiency in patients on mechanical circulatory support has not been
described.
Fever was reported in patients with pernicious anemia more than 100 years ago 4.
It usually persists after blood transfusion, despite correction of anemia, and
resolves only after B12 administration. The mechanism of the antipyretic effect of
vitamin B12 remains unclear 5,6. In this case of prolonged fever of unknown origin,
the levels of vitamin B12 was near the lower limit of the normal reference range
and the MMA level was at the upper limit of the normal reference range. Hence,
the vitamin B12 treatment was not considered at an earlier point in time. Our
patient had only transient macrocytosis. However, the typical hematological picture
of vitamin B12 deficiency may be masked by multiple blood transfusions. The
rational for the decision to start vitamin B12 treatment was based on anecdotal
evidence regarding treatment of persistent fever of unknown origin in a debilitated
patient with a mechanical mitral valve3. We observed complete resolution of the
fever four days after vitamin B12 initiation in our patient.
The patient developed severe muscular weakness, failed weaning from the
ventilator, and required a prolonged ICU stay. After initiation of vitamin B12
treatment we observed a sustained and dramatic improvement with regard to
muscle weakness and paresthesia. Demyelization of the dorsal columns and the
corticospinal tract resulting in peripheral neuropathy is a known complication of
vitamin B12 deficiency. It causes irreversible neurological damage if untreated 7,8.
A growing body of evidence demonstrates the role for vitamin B12 in the
development, progression, and treatment of different neuropsychiatric disorders 911
. To date, its role in critically ill and malnourished patients on mechanical
circulatory support has not been evaluated.
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Hemolysis with LDH ≥ 600 IU/liter (2.5-times the upper limit of laboratory normal)
has been identified as an important marker of thrombosis and adverse outcomes
after left ventricular assist device implantation12,13. Furthermore, LDH elevation in
patients with vitamin B12 deficiency is a well-recognized phenomenon and is often
associated with both intravascular and intramedullary hemolysis and thrombosis at
unusual sites14. While its mechanisms are not entirely understood, it has been
attributed to the marked hyperhomocysteinemia 15,16. Remarkably, the increased
LDH levels rapidly returned to a normal level after initiation of vitamin B12
treatment as in our case.
Our case poses several issues regarding the diagnosis and appropriate treatment
of vitamin B12 deficiency in severely debilitated and critically ill patients on
mechanical circulatory support. First, the best diagnostic approach for vitamin B12
deficiency in patients on mechanical circulatory support is unclear17. Second, the
mechanism of the antipyretic effect of vitamin B12 remained inexplicit. Vitamin B12
utilizes multiple binding proteins that facilitate its absorption and transport 18.
Deficiency of these proteins in critically ill patients may cause functional vitamin
B12 deficiency and result in additional difficulty in the diagnosis. It has been
suggested that vitamin B12 has important immunomodulatory effects and its
supplementation could correct defects caused by other biologically active
substances under the stress of prolonged severe illness, even if the vitamin B12
serum level is within the normal range19. This phenomenon is called the ‘‘Master
Key’’ effect20. Furthermore, LDH elevation in patients with vitamin B12 deficiency is
a well-recognized phenomenon and is often associated with both intravascular and
intramedullary hemolysis and thrombosis. The role of vitamin B12 in ventricular
assist device thrombosis has not yet been assessed.

Conclusion
Vitamin B 12 supplementation in our patient was delayed due to the normal levels
of vitamin B12 and MMA. However, the vitamin B12 deficiency was established by
responses to therapy. The recognition and treatment of the condition was critical in
the presented case. Since vitamin B12 has no known significant toxic effects and
has a low cost effectiveness ratio, it should be supplemented in this patient
population without delay.
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